Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNom chimique: Fmoc-4-(Boc-amino)oxy)-proline (2S,4R) // Synonymes: Fmoc-Pro(4-O-NHBoc)-OH, (2S,4R)-1-(9-fluorenmethyloxycarbonyl)-4-(((tert-butoxycarbonyl)amino)oxy)pyrrolidine-2-carboxylic acid,(2S,4R)-Fmoc-4-(((tert-butoxycarbonyl)amino)oxy)-pyrrolidine-2-carboxy lic acid, Fmoc-4-(((tert-butoxycarbonyl)amino)oxy)
from 600,00 €
Aminooxy-containing proline analogues bearing Fmoc/Boc protection suitable for the incorporation into peptides using Fmoc protocols. Deprotection of the aminooxy-function after completion of the peptide synthesis allows for oxime formation through reaction with aldehydes. This allows the post solid-phase synthesis of diverse derivative for structure-activity studies.
Protected aminooxyprolines for expedited library synthesis: Application to Tsg101-directed proline-oxime containing peptides; F. Liu, A. G. Stephen, R. J. Fisher, T. R. Burke; Med. Chem. Lett. 2008; 18: 1096-1101. https://doi.org/10.1016/j.bmcl.2007.12.003.
SAR by Oxime-Containing Peptide Libraries: Application to Tsg101 Ligand Optimization; F. Liu, A. G. Stephen, A. A. Waheed, M. J. Aman, E. O. Freed, R. J. Fisher, T. R. Burke; Chembiochem 2008; 9: 2000-2004. https://doi.org/10.1002/cbic.200800281.
Eludication of New Binding Interactions with the Human Tsg101 Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands; S.-E. Kim, F. Liu, Y. J. Im, A. G. Stephen, M. J. Fivash, A. A. Waheed, E. O. Freed, R. J. Fisher, J. H. Hurley, T. R. Burke; ACS Med. Chem. Lett. 2011; 2: 337-341. https://doi.org/10.1021/ml1002579.
Identification of High Affinity Polo-like Kinase 1 (Plk1) Polo-box Domain Binding Peptides Using Oxime-Based Diversification; F. Li, J.-E. Park, W.-J. Qian, D. Lim, A. Scharow, T. Berg, M. B. Yaffe, K. S. Lee, T. R. Burke; ACS Chem. Biol. 2012; 7: 805-810. https://doi.org/10.1021/cb200469a.
Cross-Linked Collagen Triple Helices by Oxime Ligation; N. B. Hentzen, L. E. J. Smeenk, J. Witek, S. Riniker, and H. Wennemers; J. Am. Chem. Soc. 2017; 139: 12815-12820. https://doi.org/10.1021/jacs.7b07498.